Fermented beetle powder for alcohol-related liver problems
Part of Digestive system clinical trials.
This trial tests whether a fermented powder made from a specific beetle can improve or protect the liver after alcohol-related liver injury. It’s looking for people with certain liver blood test levels, and it excludes several conditions and recent herbal or liver-affecting treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your blood test for gamma-glutamyl transferase (GGT) is higher than normal but not extremely high (up to 4 times the lab’s upper limit).
- Your liver enzymes are not very abnormal (aminotransferases are not more than 3 times the lab’s upper limit).
- Your kidneys are working fairly well (creatinine is not above 1.2 mg/dL).
- You do not have diabetes (including fasting glucose above 126 mg/dL or a known diagnosis).
- You have no history of viral hepatitis or any past cancer.
- You have not had certain recent treatments/conditions, like herbal medicine in the last 4 weeks, gastrectomy (stomach removal), psychiatric meds, uncontrolled high blood pressure, or serious heart disease (like angina/heart attack).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether specific herbal supplements can improve liver health in adults with alcohol-related liver disease. It aims to see if the supplement safely improves liver blood tests and overall liver function.
This trial is looking at bacteria inside the liver of people with alcoholic hepatitis. It may help understand how these bacteria affect the disease and lead to better treatments.
This trial studies whether a Panax ginseng extract can improve liver-related blood test results in adults. It may help people with mildly to moderately elevated liver enzymes, while carefully excluding people with other liver causes.
This Phase 2 trial studies whether a probiotic (LGG) can improve health in people with alcohol use disorder and alcohol-related liver injury. It’s not an alcohol treatment study, so participants are mainly joining to see how the supplement affects the body and liver-related outcomes.
This trial tests whether a new drug, GSK4532990, is safe and effective compared to a placebo in adults aged 18 to 70 with liver disease caused by alcohol use. The study aims to see if the drug can help treat advanced chronic liver disease.
This trial tests a new medicine called larsucosterol to see if it helps people with severe alcohol-related hepatitis (liver inflammation from heavy drinking). If you qualify, the study will monitor your safety and recovery over 90 days.
Hear when a new Alcoholic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.